News

Find News

Filter articles

Showing 81 to 90 of 2788 results

23andMe petitions Fed Circuit for en banc review

US08-11-2019Saman Javed

DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.

US government sues Gilead for patent infringement over HIV drugs

US07-11-2019Rory O'Neill

The US government is suing Gilead for patent infringement, claiming that the pharmaceutical company has been piggybacking on public research to earn billions from its HIV drugs.

Second Circuit dismisses antitrust claims against Roche

Russia, US07-11-2019Saman Javed

The US Court of Appeals for the Second Circuit has dismissed a Russian pharmaceutical company’s antitrust claims against Roche.

Pfizer and Sun settle Bosulif dispute

06-11-2019Rory O'Neill

Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.

Takeda sells generics portfolio to Stada for $660m

Germany, Russia06-11-2019Saman Javed

German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

USITC begins Olympus patent probe

US05-11-2019Rory O'Neill

The US International Trade Commission is investigating certain endoscopic devices after a German medical devices company accused Japanese optical products manufacturer Olympus of patent infringement.

Donald Trump to nominate Stephen Hahn as FDA commissioner

US05-11-2019Saman Javed

US President Donald Trump has nominated a new commissioner of the Food and Drug Administration.

Counterfeit fentanyl dealer jailed for 30 years

US04-11-2019Saman Javed

An individual who manufactured and sold counterfeit fentanyl has been sentenced to 30 years in prison by a US court.

Latham and Watkins promote three

04-11-2019Rory O'Neill

Latham and Watkins has unveiled two new IP partners and one counsel as part of its annual appointments and promotions.

EPO Board of Appeal issues communication on BI CRISPR/Cas9 patent hearing

EU04-11-2019Saman Javed

The Board of Appeal of the European Patent Office has issued new communication summarising issues that will be discussed at a hearing on whether the EPO erred in its revocation of a patent owned by the Broad Institute.

Showing 81 to 90 of 2788 results

LSIPR